COVID-19 Vaccine May Help Mesothelioma Survivors Avoid Serious Side Effects
Several new studies illustrate the importance of the COVID-19 vaccine for malignant mesothelioma patients and survivors. They suggest that people…
-
-
Biopsy | Diagnosis | Europe | International | Symptoms | Treatments
Medical Thoracoscopy Safe and Effective for Mesothelioma Diagnosis
UK researchers say a minimally invasive procedure called medical thoracoscopy is safe and effective for diagnosing mesothelioma and treating its… -
Europe | Immune Systems | International | New Drugs | Research | Treatments
ONCOS-102 Gets Fast Track Designation for Mesothelioma Treatment
An immunotherapy treatment called ONCOS-102 has received fast track designation from the FDA as a pleural mesothelioma therapy. Targovax is… -
Europe | International | New Studies | Prognosis | Research
Radiotherapy Outcomes in Mesothelioma Linked to Metabolism
Italian researchers say metabolic markers may hold the key to predicting radiotherapy outcomes in people with mesothelioma. Metabolism is the… -
Biomarkers | Diagnosis | New Studies | Prognosis | Research
Standard Biomarkers for Pleural Mesothelioma “Not Useful” for Immunotherapy
Two of the most important biomarkers for pleural mesothelioma are not much help when it comes to tracking response to… -
Chemotherapy | Europe | Genetics | International | Research | Treatments
Chemoresistance in Mesothelioma: The Role of Genetics
A team of Swiss and German researchers have a theory about why so many mesothelioma patients experience chemoresistance. Chemotherapy is… -
Diabetes Drug Triggers Mesothelioma Cell Death in New Study
A new study suggests that the diabetes drug metformin may help keep mesothelioma cells from growing and spreading. The study… -
Opdivo as Second-Line Treatment Option for Mesothelioma: Promising New Data
A new study suggests that the cancer drug Opdivo could be an effective second-line treatment option for people with relapsed… -
Maintenance Therapy with Gemcitabine Extends Mesothelioma Survival in Dutch Study
Dutch researchers say administering maintenance therapy with gemcitabine after chemotherapy may help mesothelioma patients live longer than supportive care alone. … -
Epithelioid Subtype Leads to Longer Survival Regardless of Treatment
Danish researchers say people with the epithelioid subtype of pleural mesothelioma tend to live longer than those with other subtypes,…
